An expert review of the NSCLC landscape: EGFR in focus

Learning objectives:

After watching this broadcast, participants should be able to:

• Evaluate the emerging treatment options available for EGFR-positive NSCLC
• Describe how ongoing research into EGFR exon 20 insertions might drive clinical decision-making in patients with intrinsic resistance to EGFR TKIs

Co-chairs:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)

Faculty:

• Joshua Bauml (USA)
• Luis Paz-Ares (Spain)

This educational activity has been awarded 2 CPD points by CPDUK, a globally recognised provider of CPD.